HackingHealthcareFinancial ServicesHealthcareCapture Stored DataData ExfiltratedCustomer Data InvolvedIdentity (basic)Health (basic)PIILowContained

Endo Pharmaceuticals Inc.

bd_04a77b600727039d · schema v1 · pii pii-v1

Severity

Low

Discovered

—

Filed

May 24, 2024

To disclose

—

Affected

Not disclosed

Linked

4 filings

Confidence

68%

Full breach record for Endo Pharmaceuticals Inc. →

Cencora, Inc. experienced a data breach on February 21, 2024, where personal information was exfiltrated from its systems. Lash Group, a partner, notified affected individuals on May 24, 2024. Data included names, addresses, DOBs, health diagnoses, and medications. No evidence of fraud was found. Cencora engaged law enforcement and cybersecurity experts, and offered 24 months of credit monitoring.

J jump to incidentP pin to compareR raw source

Incident timeline — partial

? — ?

Breach window unknown

May 24, 2024

Filed

No interval is drawn: no breach start or discovery date is on record for this filing.

This filing is one of 4 filings about the same incident.View merged incident

Linked disclosures

Why this link?

Regulatory filings (3) · sorted by filing gap

California State AGbd_089e48658cc8113c2024-05-24Verified
Indiana State AGbd_27bfc39f2bae95902024-05-24Verified
Montana State AGbd_3332a7bbd69677672024-05-24Candidate

Name: The Lash Group, LLC
norm: the lash

Name: Endo Pharmaceuticals Inc.
norm: endo pharmaceuticals
Industry: HealthcarellmFinancial Servicesllm

Discovered: —
Materiality determined: —
Notification sent: May 24, 2024
Affected individuals: Not disclosed
Data types: Identity (basic)Health (basic)PII
Attack vector: Unauthorized Access
MITRE ATT&CK: T1041 Exfiltration Over C2 ChannelT1119 Automated Collection
Threat actor: ExternalFinancial

During the incident: Launched an investigation with the assistance of cybersecurity experts, law enforcement, and outside lawyers
Took containment steps
Working with cybersecurity experts to reinforce our systems and information security protocols
Providing you with access to Experian IdentityWorks credit monitoring and remediation services for 24 months at no charge
Changes made: Reinforce our systems and information security protocols
Source: Quoted from the filing itself, not independently verified.

Compliance flags: — (clock not assessable for this source)

Status: No extraction artifact recorded for this disclosure.

Filing propagation · 4 filings · 4 states

View merged incident ↗

California State AGMay 24 · first

Indiana State AGMay 24 · first

Montana State AGMay 24 · first

Vermont State AGMay 24 · first · this page

Evidence ladder

Leak-site claim

Attacker assertion only. Establishes: claim date, group, alleged victim.

Press / market report

Unlocks: incident narrative, operational impact. Still no compliance clock.

State AG / regulator filingThis record

Unlocks: discovery date, data types, affected count, compliance clock.

SEC 8-K / victim statement

Unlocks: materiality, stated response, full audit trail. Ceiling removed.

Source URL: https://ago.vermont.gov/document/2024-05-24-endo-pharmaceuticals-data-breach-notice-consumers
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
Filed at: May 24, 2024
Raw hash: 9f0cbad5b708ca693f2d1c0796afa64b4ed6600dab2c74ff16db6c74991b5e12

Linked disclosures

Regulatory filings (3) · sorted by filing gap

Reporting entityThe Lash Group, LLC

Victim entityEndo Pharmaceuticals Inc.

IncidentUnauthorized Access

Stated responseLaunched an investigation with the assistance of cybersecurity experts, law enforcement, and outside lawyers

Complianceclock not assessable

Extraction provenanceno artifact recorded

Source provenanceago.vermont.gov